N8 Medical Submits IDE for Breakthrough CeraShield(TM) Endotracheal Tube Device

Plans to Initiate First-in-Human testing in First Quarter of 2018 DUBLIN, Ohio, Feb. 8, 2018 -- (Healthcare Sales & Marketing Network) -- N8 Medical, LLC today announced the submission of its Investigational Device Exemption (IDE) for its flagship Cera... Devices, FDA N8 Medical, CeraShield, Endotracheal Tube, ceragenins
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news